Molecular Partners AG EPS History: Annual & Quarterly (MOLN)

Molecular Partners AG's diluted EPS was -CHF 1.65 for fiscal 2025.

View full Molecular Partners AG company overview

Molecular Partners AG annual diluted eps history

Molecular Partners AG annual diluted eps

Diluted EPSBasic EPS
Fiscal yearPeriod endedDiluted EPSBasic EPSChangeGrowth
20252025-12-31-CHF 1.65-CHF 1.65-CHF 0.06
20242024-12-31-CHF 1.59-CHF 1.59CHF 0.30
20232023-12-31-CHF 1.89-CHF 1.89-CHF 5.43
20222022-12-31CHF 3.54CHF 3.63CHF 5.60
20212021-12-31-CHF 2.06-CHF 2.06CHF 0.45
20202020-12-31-CHF 2.51-CHF 2.51-CHF 0.82
20192019-12-31-CHF 1.69-CHF 1.69

Molecular Partners AG diluted eps trends

Over the last five fiscal years, Molecular Partners AG's diluted eps increased from -CHF 2.51 to -CHF 1.65, a change of CHF 0.86. The latest reported quarter, Q2 2026, shows -CHF 0.35.

About the metric

What earnings per share (EPS) means

Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.

Calculation and source

SEC-reported diluted and basic EPS

TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Molecular Partners AG source filings ↗

Community posts

It’s quiet here.

No posts about MOLN yet. Start the conversation.

Write the first post